Cargando…

The Association of Gross Tumor Volume and Its Radiomics Features with Brain Metastases Development in Patients with Radically Treated Stage III Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Around 30% of patients with stage III non-small cell lung cancer (NSCLC) receiving radical chemoradiotherapy will develop symptomatic brain metastases (BM) during the disease course. Identifying risk factors for BM can help improve the management of these patients. The aim of this cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Haiyan, Tohidinezhad, Fariba, De Ruysscher, Dirk K. M., Willems, Yves C. P., Degens, Juliette H. R. J., van Kampen-van den Boogaart, Vivian E. M., Pitz, Cordula, Cortiula, Francesco, Brandts, Lloyd, Hendriks, Lizza E. L., Traverso, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252119/ https://www.ncbi.nlm.nih.gov/pubmed/37296973 http://dx.doi.org/10.3390/cancers15113010

Ejemplares similares

Prediction models for treatment-induced cardiac toxicity in patients with non-small-cell lung cancer: A systematic review and meta-analysis
por: Tohidinezhad, Fariba, et al.
Publicado: (2022)

Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC
por: Keek, Simon A., et al.
Publicado: (2022)

Prediction models for brachytherapy-induced rectal toxicity in patients with locally advanced pelvic cancers: a systematic review
por: Tohidinezhad, Fariba, et al.
Publicado: (2022)

Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study
por: Degens, Juliette, et al.
Publicado: (2020)

Physical exercise at the crossroad between muscle wasting and the immune system: implications for lung cancer cachexia
por: Cortiula, Francesco, et al.
Publicado: (2022)

Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?
por: Peeters, Stephanie T. H., et al.
Publicado: (2021)

Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zeng, Haiyan, et al.
Publicado: (2022)

Biomarkers of Radiotherapy-Induced Immunogenic Cell Death
por: Vaes, Rianne D. W., et al.
Publicado: (2021)

Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
por: Hindocha, Sumeet, et al.
Publicado: (2022)

How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review
por: Remon, Jordi, et al.
Publicado: (2021)

Association of Pretreatment Physical and Geriatric Parameters with Treatment Tolerance and Survival in Elderly Patients with Stage I–II Non-Small Cell Lung Cancer: An Evaluation of Usual Care Data
por: Voorn, Melissa J. J., et al.
Publicado: (2022)

Author Correction: Gross tumour volume radiomics for prognostication of recurrence & death following radical radiotherapy for NSCLC
por: Hindocha, Sumeet, et al.
Publicado: (2022)

Predicting Adverse Radiation Effects in Brain Tumors After Stereotactic Radiotherapy With Deep Learning and Handcrafted Radiomics
por: Keek, Simon A., et al.
Publicado: (2022)

Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675)
por: Albers, Elaine A.C., et al.
Publicado: (2023)

Invasive Aspergillosis Mimicking Metastatic Lung Cancer
por: Vanfleteren, Michiel J. E. G. W., et al.
Publicado: (2018)

Feasibility of Rehabilitation during Chemoradiotherapy among Patients with Stage III Non-Small Cell Lung Cancer: A Proof-of-Concept Study
por: Voorn, Melissa J. J., et al.
Publicado: (2022)

Prediction Models for Radiation-Induced Neurocognitive Decline in Adult Patients With Primary or Secondary Brain Tumors: A Systematic Review
por: Tohidinezhad, Fariba, et al.
Publicado: (2022)

Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures
por: Larue, Ruben T H M, et al.
Publicado: (2017)

Targeted therapies for unresectable stage III non-small cell lung cancer
por: Remon, Jordi, et al.
Publicado: (2021)

Immunotherapy in small cell lung cancer: one step at a time: a narrative review
por: Dumoulin, Daphne W., et al.
Publicado: (2021)

Technical Note: Ontology‐guided radiomics analysis workflow (O‐RAW)
por: Shi, Zhenwei, et al.
Publicado: (2019)

The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab
por: Degens, Juliette H.R.J., et al.
Publicado: (2021)

First-line immune-chemotherapy combination for squamous NSCLC is already a reality
por: Hendriks, Lizza E. L., et al.
Publicado: (2020)

Repeatability and Reproducibility of Radiomic Features: A Systematic Review
por: Traverso, Alberto, et al.
Publicado: (2018)

Generation of synthetic ground glass nodules using generative adversarial networks (GANs)
por: Wang, Zhixiang, et al.
Publicado: (2022)

First results of the Maastricht brace in the treatment of adolescent idiopathic scoliosis
por: Schrander, Dirk, et al.
Publicado: (2014)

Gross alpha and gross beta activities in selected marine species in Vietnam
por: Duong Van, Hao, et al.
Publicado: (2020)

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation
por: Witlox, Willem J. A., et al.
Publicado: (2018)

Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
por: van Timmeren, Janna E., et al.
Publicado: (2019)

Review of Gross Anatomy
por: Crelin, E. S.
Publicado: (1964)

Radiomics integration into a picture archiving and communication system
por: Zhovannik, Ivan, et al.
Publicado: (2021)

Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions
por: Hartgerink, Dianne, et al.
Publicado: (2018)

Editorial: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment
por: Hendriks, Lizza E. L., et al.
Publicado: (2018)

Update on Targeted Therapies for Advanced Non-Small Cell Lung Cancer: Durvalumab in Context
por: Gullapalli, Sneha, et al.
Publicado: (2020)

Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?
por: Hendriks, Lizza E. L., et al.
Publicado: (2021)

Palliative Care for Cancer Patients During the COVID-19 Pandemic, With Special Focus on Lung Cancer
por: Schoenmaekers, Janna J. A. O., et al.
Publicado: (2020)

Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study
por: Vaes, Rianne D. W., et al.
Publicado: (2021)

Alcohol consumption in later life and reaching longevity: the Netherlands Cohort Study
por: van den Brandt, Piet A, et al.
Publicado: (2020)

Kernphysik haben große Pläne
por: Lausch, E
Publicado: (1964)

Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept
por: Berghmans, Thierry, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_on1rpi9jm997gbr5qmrsvh3hlt